Feed Hedge Funds Ban Employees from Taking Ozempic August 28, 2026 0 Min Read Share 0 Min Read SHARE Several hedge funds are reportedly prohibiting employees from using Ozempic, a popular diabetes and weight-loss medication, citing concerns about potential side effects impacting job performance. Share This Article Facebook Twitter Copy Link Leave a comment Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. CENTCOM Plans Emerge, Analysts Question Strike ImpactReports indicate CENTCOM has developed strike plans, causing oil prices to rise.… MicroStrategy Holds Q3 2026 Earnings Call with AnalystsMicroStrategy conducted its third-quarter 2026 earnings call, engaging in a question-and-answer session… Uniswap launches TJAR fee tool, benefiting fast searchersUniswap's new TJAR fee tool allows Robinhood to manage stablecoin fees, but… North Korean Hackers Breach Binance, Stealing $6.3 BillionNorth Korean hackers are estimated to have stolen over $6 billion from… Matt Hougan: US Tokenization Exemption Lacks Near-Term ActionMatt Hougan views the US tokenization exemption as promising but anticipates limited… Crypto Market Plunges Following Binance Hack IncidentThe cryptocurrency market experienced a significant downturn this week, largely attributed to…
